Drug intelligence / Profile preview

Bevida

Development stage
Phase 3
Lead developer
Euro Med Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

Bevida is a parenteral vitamin B-complex formulation developed and manufactured by Euro-Med Laboratories in the Philippines. It typically consists of a combination of Thiamine (Vitamin B1), Pyridoxine (Vitamin B6), and Cyanocobalamin (Vitamin B12). The drug is indicated for the treatment and prevention of vitamin B deficiencies and is frequently used in the management of neurological conditions such as neuritis, polyneuritis, and neuralgia. As a solution for injection, Bevida provides rapid replenishment of essential cofactors required for carbohydrate metabolism, amino acid synthesis, and the maintenance of the myelin sheath in nerve cells. It is commercially available in the Philippines as an approved pharmaceutical product for intramuscular or intravenous administration.

Brand names
Bevida
Other names
Vitamin B1 + B6 + B12Vitamin B-complex
02

Targets

BCKDHB (2-oxoisovalerate dehydrogenase subunit beta, mitochondrial)1C metabolism (One-carbon metabolism)THTR (Thiamine transporter 1)

Beyond the preview

Go deeper on Bevida.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bevida.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call